Potent Type-Specific De Novo Antibodies Complement Broadly Reactive Imprinted Antibodies in Immune Responses to SARS-CoV-2 Variants

Researchers isolated and characterized hundreds of recall and de novo neutralizing monoclonal antibodies after sequential exposures to SARS-CoV-2 variants in ancestral-imprinted humans.